Precision Medicine Market Report 2023-2033

Overall world revenue for Precision Medicine Market, 2023 to 2033 in terms of value will surpass US$78 billion in 2023. The publisher predicts strong revenue growth through to 2033. This work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

The Precision Medicine Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Expanding Applications of Precision Medicine and Rising Demand for Targeted Therapy

With regard to genetic disorders, precision medicine is becoming more prevalent. In the domains of neurogenetics, cardiovascular genomics, and rare illness genetic testing, this method is being employed more frequently. Additionally, non-invasive prenatal testing, pharmacogenomics, and screening genetic risk for hereditary diseases are also becoming more prevalent applications of precision medicine. A number of pharmaceutical companies are also concentrating on the creation of precision medicine for neurological conditions like Alzheimer's and Parkinson's disease. Pharmacological, biopharmaceutical, and pharmaceutical firms are continuously working to integrate patient-selection diagnostic frameworks into the earlier phases of drug development in order to deliver targeted therapies to the appropriate candidate and support the expansion of the precision medicine market. One of the main causes of the expanding usage of genomes and proteomics technologies as well as precision medicine is the increased understanding of the advantages of personalised medicine. Individualised treatment plans for many chronic diseases and conditions must include precision medicine, which entails the investigation of specific indications for particular medications in a given patient.

High Cost of Precision Medicine

Although personalized treatments are well-established in the pharmaceutical business, their cost continues to prevent payers, patients, and doctors from accessing them. Despite offering guaranteed returns on investment, the high initial cost of these tests makes them inaccessible to a huge majority of end users, particularly those in poor nations. As a result, end users like pharmaceutical firms, reference labs, medical facilities, and CROs who view the cost of such diagnostic procedures as a burden choose to use third-party precision diagnostic services. Inevitably, current medical privacy and investigation guidelines are inadequate to allow for the collection of enormous amounts of data on large patient populations, and private healthcare systems lack the infrastructure to do so, which drives up the price of precision medicine even more.

What Questions Should You Ask before buying a Market Research Report?

How is the precision medicine market evolving?
What is driving and restraining the precision medicine market?
How will each point of care diagnostic submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
How will the market shares for each precision medicine submarket develop from 2022 to 2033?
What will be the main driver for the overall market from 2023 to 2033?
Will leading precision medicine markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
Who are the leading players and what are their prospects over the forecast period?
What are the precision medicine projects for these leading companies?
How will the industry evolve during the period between 2023 and 2033? What are the implications of precision medicine projects taking place now and over the next 10 years?
Is there a greater need for product commercialisation to further scale the precision medicine market?
Where is the precision medicine market heading and how can you ensure you are at the forefront of the market?
What are the best investment options for new product and service lines?
What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the Precision Medicine market today, and over the next 10 years:

The 347-page report provides 149 tables, 220 charts, and graphs exclusively to you.
The report highlights key lucrative areas in the industry so you can target them - NOW.
It contains in-depth analysis of global, regional and national sales and growth.
It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the Precision Medicine market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects

In addition to revenue forecasting to 2033, this new study provides you with recent results, growth rates, and market shares.
You will find original analyses, with business outlooks and developments.
Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising Precision Medicine prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

Product

Diagnostic
Genetic Tests
Biomarker Based Tests
Other Diagnostic Tests
Therapeutics

Application

Oncology
CNS
Immunology
Respiratory
Others

Technology

Drug Discovery
Bioinformatics
Big Data Analytics
Gene Sequencing
Companion Diagnostics
Other Technologies

End-user

Hospitals
Diagnostic Centres
Research & Academic Institutes
Other End-users

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 25 leading national markets:

North America

U.S.
Canada

Europe

Germany
UK
France
Italy
Spain
Switzerland
Netherlands
Rest of Europe

Asia Pacific

China
Japan
India
Australia
South Korea
Singapore
Rest of Asia Pacific

Latin America

Brazil
Mexico
Argentina
Rest of Latin America

MEA

GCC
South Africa
Egypt
Rest of MEA

The report also includes profiles and for some of the leading companies in the Precision Medicine Market, 2023 to 2033, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth

Abbott
Abnova Corporation
Agilent Technologies Inc.
AstraZeneca
Bayer AG
Biogen
bioMérieux SA
Bristol-Myers Squibb Company
Danaher
F. Hoffmann-La Roche Ltd
GE HealthCare
GSK plc
Illumina, Inc.
Johnson & Johnson Services, Inc.
Laboratory Corporation of America Holdings
Lilly
Myriad Genetics Inc.
NanoString Technologies, Inc.
Novartis AG
Pfizer Inc.
Qiagen
Quest Diagnostics Incorporated
Teva Pharmaceutical Industries Ltd.
Thermo Fisher Scientific Inc.

How will the Precision Medicine Market, 2023 to 2033 report help you?

In summary, the 340+ page report provides you with the following knowledge:

Revenue forecasts to 2033 for Precision Medicine Market, 2023 to 2033 Market, with forecasts for product, mode, sample, platform, end user, each forecast at a global and regional level - discover the industry’s prospects, finding the most lucrative places for investments and revenues.
Revenue forecasts to 2033 for five regional and 25 key national markets - See forecasts for the Precision Medicine Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, Spain, Switzerland, Netherlands, China, India, Japan, Australia, South Korea, Singapore, Argentina, GCC, South Africa, and Egypt among other prominent economies.
Prospects for established firms and those seeking to enter the market - including company profiles for 25 of the major companies involved in the Precision Medicine Market, 2023 to 2033.

Find quantitative and qualitative analyses with independent predictions. Receive information that only this report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With this new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how the work could benefit your research, analyses, and decisions. The study is for everybody needing commercial analyses for the Precision Medicine Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.

1 Report Overview

1.1 Objectives of the Study
1.2 Introduction to Precision Medicine Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Reports
1.10 About

2 Executive Summary

3 Market Overview

3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Increasing Global Burden of Cancer Boosts the Demand for Personalized Medicine
3.2.1.2 Increase in Scope of Application of Precision Medicine
3.2.1.3 Accelerating Demand for Targeted Therapy
3.2.1.4 Growing Precedence of Precision Medicine Over Traditional Practice of “One-Size-Fits-All” Therapies
3.2.2 Market Restraining Factors
3.2.2.1 High Cost of Precision Medicine
3.2.2.2 Lack of Data Interoperability
3.2.2.3 Insufficient Funding for Diagnostics Space in the Emerging Economies
3.2.3 Market Opportunities
3.2.3.1 Growing Use of AI in Healthcare Is Boosting Demand for Precision Medicine
3.2.3.2 Growing acceptance of gene therapy and gene editing technology
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Supplier
3.4.2 Bargaining Power of Buyers
3.4.3 Threat of New Entrants
3.4.4 Threat from Substitutes
3.4.5 Competitive Rivalry
3.5 SWOT Analysis
3.6 PEST Analysis

4 Precision Medicine Market Analysis by Product Type

4.1 Key Findings
4.2 Product Type Segment: Market Attractiveness Index
4.3 Precision Medicine Market Size Estimation and Forecast by Product Type
4.4 Diagnostics
4.4.1 Market Size by Region, 2023-2033 (US$ Billion)
4.4.2 Market Share by Region, 2023 & 2033 (%)
4.4.3 Genetic Tests
4.4.3.1 Market Size by Region, 2023-2033 (US$ Billion)
4.4.3.2 Market Share by Region, 2023 & 2033 (%)
4.4.4 Biomarker Based Tests
4.4.4.1 Market Size by Region, 2023-2033 (US$ Billion)
4.4.4.2 Market Share by Region, 2023 & 2033 (%)
4.4.5 Others
4.4.5.1 Market Size by Region, 2023-2033 (US$ Billion)
4.4.5.2 Market Share by Region, 2023 & 2033 (%)
4.5 Therapeutics
4.5.1 Market Size by Region, 2023-2033 (US$ Billion)
4.5.2 Market Share by Region, 2023 & 2033 (%)

5 Precision Medicine Market, by Application, 2023-2033

5.1 Key Findings
5.2 Application Segment: Market Attractiveness Index
5.3 Precision Medicine Market, by Application
5.4 Oncology
5.4.1 Market Size by Region, 2023-2033 (US$ Billion)
5.4.2 Market Share by Region, 2023 & 2033 (%)
5.5 CNS
5.5.1 Market Size by Region, 2023-2033 (US$ Billion)
5.5.2 Market Share by Region, 2023 & 2033 (%)
5.6 Immunology
5.6.1 Market Size by Region, 2023-2033 (US$ Billion)
5.6.2 Market Share by Region, 2023 & 2033 (%)
5.7 Respiratory
5.7.1 Market Size by Region, 2023-2033 (US$ Billion)
5.7.2 Market Share by Region, 2023 & 2033 (%)
5.8 Others
5.8.1 Market Size by Region, 2023-2033 (US$ Billion)
5.8.2 Market Share by Region, 2023 & 2033 (%)

6 Precision Medicine Market, by Technology, 2023-2033

6.1 Key Findings
6.2 Technology Segment: Market Attractiveness Index
6.3 Precision Medicine Market Size Estimation and Forecast by Technology
6.4 Drug Discovery
6.4.1 Market Size by Region, 2023-2033 (US$ Billion)
6.4.2 Market Share by Region, 2023 & 2033 (%)
6.5 Bioinformatics
6.5.1 Market Size by Region, 2023-2033 (US$ Billion)
6.5.2 Market Share by Region, 2023 & 2033 (%)
6.6 Big Data Analytics
6.6.1 Market Size by Region, 2023-2033 (US$ Billion)
6.6.2 Market Share by Region, 2023 & 2033 (%)
6.7 Gene Sequencing
6.7.1 Market Size by Region, 2023-2033 (US$ Billion)
6.7.2 Market Share by Region, 2023 & 2033 (%)
6.8 Companion Diagnostics
6.8.1 Market Size by Region, 2023-2033 (US$ Billion)
6.8.2 Market Share by Region, 2023 & 2033 (%)
6.9 Other Technologies
6.9.1 Market Size by Region, 2023-2033 (US$ Billion)
6.9.2 Market Share by Region, 2023 & 2033 (%)

7 Precision Medicine Market, by End-users, 2023-2033

7.1 Key Findings
7.2 End-users Segment: Market Attractiveness Index
7.3 Precision Medicine Market Size Estimation and Forecast by End-users
7.4 Hospitals
7.4.1 Market Size by Region, 2023-2033 (US$ Billion)
7.4.2 Market Share by Region, 2023 & 2033 (%)
7.5 Diagnostic centres
7.5.1 Market Size by Region, 2023-2033 (US$ Billion)
7.5.2 Market Share by Region, 2023 & 2033 (%)
7.6 Research & Academic Institutes
7.6.1 Market Size by Region, 2023-2033 (US$ Billion)
7.6.2 Market Share by Region, 2023 & 2033 (%)
7.7 Other End-users
7.7.1 Market Size by Region, 2023-2033 (US$ Billion)
7.7.2 Market Share by Region, 2023 & 2033 (%)

8 Precision Medicine Market Analysis by Region

8.1 Key Findings
8.2 Regional Market Size Estimation and Forecast

9 North America Precision Medicine Market Analysis

9.1 Key Findings
9.2 North America Precision Medicine Market Attractiveness Index
9.3 North America Precision Medicine Market by Country, 2023, 2028 & 2033 (US$ Billion)
9.4 North America Precision Medicine Market Size Estimation and Forecast by Country
9.5 North America Precision Medicine Market Size Estimation and Forecast by Product Type
9.6 North America Precision Medicine Market Size Estimation and Forecast by Application
9.7 North America Precision Medicine Market Size Estimation and Forecast by Technology
9.8 North America Precision Medicine Market Size Estimation and Forecast by End-users
9.9 U.S. Precision Medicine Market Analysis
9.10 Canada Precision Medicine Market Analysis

10 Europe Precision Medicine Market, 2023-2033

10.1 Key Findings
10.2 Europe Precision Medicine Market Attractiveness Index
10.3 Europe Precision Medicine Market by Country, 2023, 2028 & 2033 (US$ Billion)
10.4 Europe Precision Medicine Market Size Estimation and Forecast by Country
10.5 Europe Precision Medicine Market Size Estimation and Forecast by Product Type
10.6 Europe Precision Medicine Market Size Estimation and Forecast by Application
10.7 Europe Precision Medicine Market Size Estimation and Forecast by Technology
10.8 Europe Precision Medicine Market Size Estimation and Forecast by End-users
10.9 Germany Precision Medicine Market Analysis
10.10 UK Precision Medicine Market Analysis
10.11 France Precision Medicine Market Analysis
10.12 Italy Precision Medicine Market Analysis
10.13 Spain Precision Medicine Market Analysis
10.14 Switzerland Precision Medicine Market Analysis
10.15 Netherlands Precision Medicine Market Analysis
10.16 Rest of Europe Precision Medicine Market Analysis

11 Asia Pacific Precision Medicine Market Analysis

11.1 Key Findings
11.2 Asia Pacific Precision Medicine Market Attractiveness Index
11.3 Asia Pacific Precision Medicine Market by Country, 2023, 2028 & 2033 (US$ Billion)
11.4 Asia Pacific Precision Medicine Market Size Estimation and Forecast by Country
11.5 Asia Pacific Precision Medicine Market Size Estimation and Forecast by Product Type
11.6 Asia Pacific Precision Medicine Market Size Estimation and Forecast by Application
11.7 Asia Pacific Precision Medicine Market Size Estimation and Forecast by Technology
11.8 Asia Pacific Precision Medicine Market Size Estimation and Forecast by End-users
11.9 Japan Precision Medicine Market Analysis
11.10 China Precision Medicine Market Analysis
11.11 India Precision Medicine Market Analysis
11.12 Australia Precision Medicine Market Analysis
11.13 South Korea Precision Medicine Market Analysis
11.14 Singapore Precision Medicine Market Analysis
11.15 Rest of Asia Pacific Precision Medicine Market Analysis

12 Latin America Precision Medicine Market Analysis

12.1 Key Findings
12.2 Latin America Precision Medicine Market Attractiveness Index
12.3 Latin America Precision Medicine Market by Country, 2023, 2028 & 2033 (US$ Billion)
12.4 Latin America Precision Medicine Market Size Estimation and Forecast by Country
12.5 Latin America Precision Medicine Market Size Estimation and Forecast by Product Type
12.6 Latin America Precision Medicine Market Size Estimation and Forecast by Application
12.7 Latin America Precision Medicine Market Size Estimation and Forecast by Technology
12.8 Latin America Precision Medicine Market Size Estimation and Forecast by End-users
12.9 Brazil Precision Medicine Market Analysis
12.10 Mexico Precision Medicine Market Analysis
12.11 Argentina Precision Medicine Market Analysis
12.12 Rest of Latin America Precision Medicine Market Analysis

13 MEA Precision Medicine Market Analysis

13.1 Key Findings
13.2 MEA Precision Medicine Market Attractiveness Index
13.3 MEA Precision Medicine Market by Country, 2023, 2028 & 2033 (US$ Billion)
13.4 MEA Precision Medicine Market Size Estimation and Forecast by Country
13.5 MEA Precision Medicine Market Size Estimation and Forecast by Product Type
13.6 MEA Precision Medicine Market Size Estimation and Forecast by Application
13.7 MEA Precision Medicine Market Size Estimation and Forecast by Technology
13.8 MEA Precision Medicine Market Size Estimation and Forecast by End-users
13.9 GCC Precision Medicine Market Analysis
13.10 South Africa Precision Medicine Market Analysis
13.11 Egypt Precision Medicine Market Analysis
13.12 Rest of MEA Precision Medicine Market Analysis

14 Company Profiles

14.1 Competitive Landscape, 2022
14.2 Pfizer Inc.
14.2.1 Company Snapshot
14.2.2 Company Overview
14.2.3 Financial Analysis
14.2.3.1 Net Revenue, 2018-2022
14.2.3.2 R&D, 2018-2022
14.2.3.3 Regional Market Shares, 2022
14.2.4 Product Benchmarking
14.2.5 Strategic Outlook
14.3 Qiagen
14.3.1 Company Snapshot
14.3.2 Company Overview
14.3.3 Financial Analysis
14.3.3.1 Net Revenue, 2018-2022
14.3.3.2 R&D, 2018-2022
14.3.3.3 Regional Market Shares, 2022
14.3.4 Product Benchmarking
14.3.5 Strategic Outlook
14.4 Quest Diagnostics Incorporated
14.4.1 Company Snapshot
14.4.2 Company Overview
14.4.3 Financial Analysis
14.4.3.1 Net Revenue, 2018-2022
14.4.4 Product Benchmarking
14.4.5 Strategic Outlook
14.5 Agilent Technologies Inc.
14.5.1 Company Snapshot
14.5.2 Company Overview
14.5.3 Financial Analysis
14.5.3.1 Net Revenue, 2018-2022
14.5.3.2 R&D, 2018-2022
14.5.3.3 Regional Market Shares, 2022
14.5.4 Product Benchmarking
14.5.5 Strategic Outlook
14.6 Illumina, Inc.
14.6.1 Company Snapshot
14.6.2 Company Overview
14.6.3 Financial Analysis
14.6.3.1 Net Revenue, 2018-2022
14.6.3.2 R&D, 2018-2022
14.6.3.3 Regional Market Shares, 2022
14.6.4 Product Benchmarking
14.6.5 Strategic Outlook
14.7 Novartis AG
14.7.1 Company Snapshot
14.7.2 Company Overview
14.7.3 Financial Analysis
14.7.3.1 Net Revenue, 2018-2022
14.7.3.2 R&D, 2018-2022
14.7.3.3 Regional Market Shares, 2022
14.7.4 Product Benchmarking
14.7.5 Strategic Outlook
14.8 bioMerieux SA
14.8.1 Company Snapshot
14.8.2 Company Overview
14.8.3 Financial Analysis
14.8.3.1 Net Revenue, 2018-2022
14.8.3.2 R&D, 2018-2022
14.8.3.3 Regional Market Shares, 2022
14.8.4 Product Benchmarking
14.8.5 Strategic Outlook
14.9 F. Hoffmann-La Roche Ltd
14.9.1 Company Snapshot
14.9.2 Company Overview
14.9.3 Financial Analysis
14.9.3.1 Net Revenue, 2018-2022
14.9.3.2 R&D, 2018-2022
14.9.3.3 Regional Market Shares, 2022
14.9.4 Product Benchmarking
14.9.5 Strategic Outlook
14.10 Abbott
14.10.1 Company Snapshot
14.10.2 Company Overview
14.10.3 Financial Analysis
14.10.3.1 Net Revenue, 2018-2022
14.10.3.2 R&D, 2018-2022
14.10.3.3 Regional Market Shares, 2022
14.10.4 Product Benchmarking
14.10.5 Strategic Outlook
14.11 Lilly
14.11.1 Company Snapshot
14.11.2 Company Overview
14.11.3 Financial Analysis
14.11.3.1 Net Revenue, 2018-2022
14.11.3.2 R&D, 2018-2022
14.11.3.3 Regional Market Shares, 2022
14.11.4 Product Benchmarking
14.11.5 Strategic Outlook
14.12 Thermo Fisher Scientific Inc.
14.12.1 Company Snapshot
14.12.2 Company Overview
14.12.3 Financial Analysis
14.12.3.1 Net Revenue, 2018-2022
14.12.3.2 R&D, 2018-2022
14.12.3.3 Regional Market Shares, 2022
14.12.4 Product Benchmarking
14.12.5 Strategic Outlook
14.13 AstraZeneca
14.13.1 Company Snapshot
14.13.2 Company Overview
14.13.3 Financial Analysis
14.13.3.1 Net Revenue, 2018-2022
14.13.3.2 R&D, 2018-2022
14.13.3.3 Regional Market Shares, 2022
14.13.4 Product Benchmarking
14.13.5 Strategic Outlook
14.14 Myriad Genetics Inc
14.14.1 Company Snapshot
14.14.2 Company Overview
14.14.3 Financial Analysis
14.14.3.1 Net Revenue, 2018-2022
14.14.3.2 R&D, 2018-2022
14.14.3.3 Regional Market Shares, 2022
14.14.4 Product Benchmarking
14.14.5 Strategic Outlook
14.15 GSK plc
14.15.1 Company Snapshot
14.15.2 Company Overview
14.15.3 Financial Analysis
14.15.3.1 Net Revenue, 2018-2022
14.15.3.2 R&D, 2018-2022
14.15.3.3 Regional Market Shares, 2022
14.15.4 Product Benchmarking
14.15.5 Strategic Outlook
14.16 Bristol-Myers Squibb Company
14.16.1 Company Snapshot
14.16.2 Company Overview
14.16.3 Financial Analysis
14.16.3.1 Net Revenue, 2018-2022
14.16.3.2 R&D, 2018-2022
14.16.3.3 Regional Market Shares, 2022
14.16.4 Product Benchmarking
14.16.5 Strategic Outlook
14.17 Danaher
14.17.1 Company Snapshot
14.17.2 Company Overview
14.17.3 Financial Analysis
14.17.3.1 Net Revenue, 2018-2022
14.17.3.2 R&D, 2018-2022
14.17.3.3 Regional Market Shares, 2022
14.17.4 Product Benchmarking
14.17.5 Strategic Outlook
14.18 Laboratory Corporation of America Holdings
14.18.1 Company Snapshot
14.18.2 Company Overview
14.18.3 Financial Analysis
14.18.3.1 Net Revenue, 2018-2022
14.18.3.2 Regional Market Shares, 2022
14.18.4 Product Benchmarking
14.18.5 Strategic Outlook
14.19 GE HealthCare
14.19.1 Company Snapshot
14.19.2 Company Overview
14.19.3 Financial Analysis
14.19.3.1 Net Revenue, 2018-2022
14.19.3.2 Regional Market Shares, 2022
14.19.4 Product Benchmarking
14.19.5 Strategic Outlook
14.20 Teva Pharmaceutical Industries Ltd.
14.20.1 Company Snapshot
14.20.2 Company Overview
14.20.3 Financial Analysis
14.20.3.1 Net Revenue, 2018-2022
14.20.3.2 R&D, 2018-2022
14.20.3.3 Regional Market Shares, 2022
14.20.4 Product Benchmarking
14.20.5 Strategic Outlook
14.21 NanoString Technologies, Inc.
14.21.1 Company Snapshot
14.21.2 Company Overview
14.21.3 Financial Analysis
14.21.3.1 Net Revenue, 2018-2022
14.21.3.2 R&D, 2018-2022
14.21.3.3 Regional Market Shares, 2022
14.21.4 Product Benchmarking
14.21.5 Strategic Outlook
14.22 Bayer AG
14.22.1 Company Snapshot
14.22.2 Company Overview
14.22.3 Financial Analysis
14.22.3.1 Net Revenue, 2018-2022
14.22.3.2 R&D, 2018-2022
14.22.3.3 Regional Market Shares, 2022
14.22.4 Product Benchmarking
14.22.5 Strategic Outlook
14.23 Biogen
14.23.1 Company Snapshot
14.23.2 Company Overview
14.23.3 Financial Analysis
14.23.3.1 Net Revenue, 2018-2022
14.23.3.2 R&D, 2018-2022
14.23.3.3 Regional Market Shares, 2022
14.23.4 Product Benchmarking
14.23.5 Strategic Outlook
14.24 Johnson & Johnson Services, Inc.
14.24.1 Company Snapshot
14.24.2 Company Overview
14.24.3 Financial Analysis
14.24.3.1 Net Revenue, 2018-2022
14.24.3.2 R&D, 2018-2022
14.24.3.3 Regional Market Shares, 2022
14.24.4 Product Benchmarking
14.24.5 Strategic Outlook

15 Conclusion and Recommendations

15.1 Concluding Remarks
15.2 Recommendations for Market Players

List of Tables

Table 1 Precision Medicine Market Snapshot, 2023 & 2033 (US$ Billion, CAGR %)
Table 2 Precision Medicine Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%): “V” Shaped Recovery
Table 3 Precision Medicine Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%): “U” Shaped Recovery
Table 4 Precision Medicine Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%): “W” Shaped Recovery
Table 5 Precision Medicine Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%): “L” Shaped Recovery
Table 6 Precision Medicine Market Forecast by Product Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 7 Diagnostics Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 8 Genetic Tests Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 9 Biomarker Based Tests Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 10 Others Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 11 Therapeutics Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 12 Precision Medicine Market by Application, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 13 Oncology Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 14 CNS Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 15 Immunology Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 16 Respiratory Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 17 Others Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 18 Precision Medicine Market Forecast by Technology, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 19 Drug Discovery Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 20 Bioinformatics Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 21 Big Data Analytics Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 22 Gene Sequencing Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
Table 23 Companion Diagnostics Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 24 Other Technologies Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 25 Precision Medicine Market Forecast by End-users, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 26 Hospitals Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 27 Diagnostic Centres Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 28 Research & academic institutes Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 29 Other End-users Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 30 Precision Medicine Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 31 North America Precision Medicine Market Forecast by Country, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 32 North America Precision Medicine Market Forecast by Product Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 33 North America Precision Medicine Market Forecast by Application, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 34 North America Precision Medicine Market Forecast by Technology, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 35 North America Precision Medicine Market Forecast by End-users, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 36 U.S. Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 37 Canada Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 38 Europe Precision Medicine Market Forecast by Country, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 39 Europe Precision Medicine Market Forecast by Product Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 40 Europe Precision Medicine Market Forecast by Application, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 41 Europe Precision Medicine Market Forecast by Technology, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 42 Europe Precision Medicine Market Forecast by End-users, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 43 Germany Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 44 UK Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 45 France Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 46 Italy Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 47 Spain Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 48 Switzerland Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 49 Netherlands Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 50 Rest of Europe Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 51 Asia Pacific Precision Medicine Market Forecast by Country, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 52 Asia Pacific Precision Medicine Market Forecast by Product Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 53 Asia Pacific Precision Medicine Market Forecast by Application, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 54 Asia Pacific Precision Medicine Market Forecast by Technology, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 55 Asia Pacific Precision Medicine Market Forecast by End-users, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 56 Japan Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 57 China Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 58 India Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 59 Australia Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 60 South Korea Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 61 Singapore Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 62 Rest of Asia Pacific Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 63 Latin America Precision Medicine Market Forecast by Country, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 64 Latin America Precision Medicine Market Forecast by Product Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 65 Latin America Precision Medicine Market Forecast by Application, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 66 Latin America Precision Medicine Market Forecast by Technology, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 67 Latin America Precision Medicine Market Forecast by End-users, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 68 Brazil Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 69 Mexico Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 70 Argentina Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 71 Rest of Latin America Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 72 MEA Precision Medicine Market Forecast by Country, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 73 MEA Precision Medicine Market Forecast by Product Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 74 MEA Precision Medicine Market Forecast by Application, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 75 MEA Precision Medicine Market Forecast by Technology, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 76 MEA Precision Medicine Market Forecast by End-users, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 77 GCC Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 78 South Africa Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 79 Egypt Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 80 Rest of MEA Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 81 Pfizer Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 82 Pfizer Inc.: Product Benchmarking
Table 83 Pfizer Inc.: Strategic Outlook
Table 84 Qiagen: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 85 Qiagen: Product Benchmarking
Table 86 Qiagen: Strategic Outlook
Table 87 Quest Diagnostics Incorporated: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 88 Quest Diagnostics Incorporated: Product Benchmarking
Table 89 Quest Diagnostics Incorporated: Strategic Outlook
Table 90 Agilent Technologies Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 91 Agilent Technologies Inc.: Product Benchmarking
Table 92 Agilent Technologies Inc.: Strategic Outlook
Table 93 Illumina, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 94 Illumina, Inc.: Product Benchmarking
Table 95 Illumina, Inc.: Strategic Outlook
Table 96 Novartis AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 97 Novartis AG: Product Benchmarking
Table 98 Novartis AG: Strategic Outlook
Table 99 bioMerieux SA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 100 bioMerieux SA: Product Benchmarking
Table 101 bioMerieux SA: Strategic Outlook
Table 102 F. Hoffmann-La Roche Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 103 F. Hoffmann-La Roche Ltd.: Product Benchmarking
Table 104 F. Hoffmann-La Roche Ltd.: Strategic Outlook
Table 105 Abbott : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 106 Abbott: Product Benchmarking
Table 107 Abbott: Strategic Outlook
Table 108 Lilly: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 109 Lilly: Product Benchmarking
Table 110 Lilly: Strategic Outlook
Table 111 Thermo Fisher Scientific Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 112 Thermo Fisher Scientific Inc.: Product Benchmarking
Table 113 Thermo Fisher Scientific Inc.: Strategic Outlook
Table 114 AstraZeneca: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 115 AstraZeneca: Product Benchmarking
Table 116 AstraZeneca: Strategic Outlook
Table 117 Myriad Genetics Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 118 Myriad Genetics Inc.: Product Benchmarking
Table 119 Myriad Genetics Inc.: Strategic Outlook
Table 120 GSK plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 121 GSK plc: Product Benchmarking
Table 122 GSK plc: Strategic Outlook
Table 123 Bristol-Myers Squibb Company Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 124 Bristol-Myers Squibb Company: Product Benchmarking
Table 125 Bristol-Myers Squibb Company: Strategic Outlook
Table 126 Danaher : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 127 Danaher: Product Benchmarking
Table 128 Danaher: Strategic Outlook
Table 129 Laboratory Corporation of America Holdings: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 130 Laboratory Corporation of America Holdings: Product Benchmarking
Table 131 Laboratory Corporation of America Holdings: Strategic Outlook
Table 132 GE HealthCare: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 133 GE HealthCare: Product Benchmarking
Table 134 GE HealthCare: Strategic Outlook
Table 135 Teva Pharmaceutical Industries Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 136 Teva Pharmaceutical Industries Ltd.: Product Benchmarking
Table 137 Teva Pharmaceutical Industries Ltd.: Strategic Outlook
Table 138 NanoString Technologies, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 139 NanoString Technologies, Inc.: Product Benchmarking
Table 140 NanoString Technologies, Inc.: Strategic Outlook
Table 141 Bayer AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 142 Bayer AG: Product Benchmarking
Table 143 Bayer AG: Strategic Outlook
Table 144 Biogen: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 145 Biogen: Product Benchmarking
Table 146 Biogen: Strategic Outlook
Table 147 Johnson & Johnson Services, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 148 Johnson & Johnson Services, Inc.: Product Benchmarking
Table 149 Johnson & Johnson Services, Inc.: Strategic Outlook

List of Figures

Figure 1 Precision Medicine Market Segmentation
Figure 2 Precision Medicine Market Attractiveness Index by Region
Figure 3 Precision Medicine Market by Product Type: Market Attractiveness Index
Figure 4 Precision Medicine Market by Application: Market Attractiveness Index
Figure 5 Precision Medicine Market by Technology: Market Attractiveness Index
Figure 6 Precision Medicine Market by End-users: Market Attractiveness Index
Figure 7 Precision Medicine Market: Market Dynamics
Figure 8 Precision Medicine Market by Region, 2023-2033 (US$ Billion, AGR %): “V” Shaped Recovery
Figure 9 Precision Medicine Market by Region, 2023-2033 (US$ Billion, AGR %): “U” Shaped Recovery
Figure 10 Precision Medicine Market by Region, 2023-2033 (US$ Billion, AGR %): “W” Shaped Recovery
Figure 11 Precision Medicine Market by Region, 2023-2033 (US$ Billion, AGR %): “L” Shaped Recovery
Figure 12 Precision Medicine Market: Porter’s Five Forces Analysis
Figure 13 Global Precision Medicine Market: SWOT Analysis
Figure 14 Precision Medicine Market: PEST Analysis
Figure 15 Precision Medicine Market by Product Type: Market Attractiveness Index
Figure 16 Precision Medicine Market Forecast by Product Type, 2023-2033 (US$ Billion, AGR %)
Figure 17 Precision Medicine Market Share Forecast by Product Type, 2023, 2028, 2033 (%)
Figure 18 Diagnostics Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
Figure 19 Diagnostics Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 20 Genetic Tests Market Forecast by Region, 2023-2033 (US$ Billion)
Figure 21 Genetic Tests Market Share Forecast by Region, 2023 & 2033 (%)
Figure 22 Biomarker Based Tests Market Forecast by Region, 2023-2033 (US$ Billion)
Figure 23 Biomarker Based Tests Market Share Forecast by Region, 2023 & 2033 (%)
Figure 24 Others Market Forecast by Region, 2023-2033 (US$ Billion)
Figure 25 Others Market Share Forecast by Region, 2023 & 2033 (%)
Figure 26 Therapeutics Market Forecast by Region, 2023-2033 (US$ Billion)
Figure 27 Therapeutics Market Share Forecast by Region, 2023 & 2033 (%)
Figure 28 Precision Medicine Market by Application: Market Attractiveness Index
Figure 29 Precision Medicine Market by Application, 2023-2033 (US$ Billion)
Figure 30 Precision Medicine Market Share Forecast by Application, 2023, 2028, 2033 (%)
Figure 31 Oncology Market Forecast by Region, 2023-2033 (US$ Billion)
Figure 32 Oncology Market Share Forecast by Region, 2023 & 2033 (%)
Figure 33 CNS Market Forecast by Region, 2023-2033 (US$ Billion)
Figure 34 CNS Market Share Forecast by Region, 2023 & 2033 (%)
Figure 35 Immunology Market Forecast by Region, 2023-2033 (US$ Billion)
Figure 36 Immunology Market Share Forecast by Region, 2023 & 2033 (%)
Figure 37 Respiratory Market Forecast by Region, 2023-2033 (US$ Billion)
Figure 38 Respiratory Market Share Forecast by Region, 2023 & 2033 (%)
Figure 39 Others Market Forecast by Region, 2023-2033 (US$ Billion)
Figure 40 Others Market Share Forecast by Region, 2023 & 2033 (%)
Figure 41 Precision Medicine Market by Technology: Market Attractiveness Index
Figure 42 Precision Medicine Market Forecast by Technology, 2023-2033 (US$ Billion)
Figure 43 Precision Medicine Market Share Forecast by Technology, 2023, 2028, 2033 (%)
Figure 44 Drug Discovery Market Forecast by Region, 2023-2033 (US$ Billion)
Figure 45 Drug Discovery Market Share Forecast by Region, 2023 & 2033 (%)
Figure 46 Bioinformatics Market Forecast by Region, 2023-2033 (US$ Billion)
Figure 47 Bioinformatics Market Share Forecast by Region, 2023 & 2033 (%)
Figure 48 Big Data Analytics Market Forecast by Region, 2023-2033 (US$ Billion)
Figure 49 Big Data Analytics Market Share Forecast by Region, 2023 & 2033 (%)
Figure 50 Gene Sequencing Market Forecast by Region, 2023-2033 (US$ Billion)
Figure 51 Gene Sequencing Market Share Forecast by Region, 2023 & 2033 (%)
Figure 52 Companion Diagnostics Market Forecast by Region, 2023-2033 (US$ Billion)
Figure 53 Companion Diagnostics Market Share Forecast by Region, 2023 & 2033 (%)
Figure 54 Other Technologies Market Forecast by Region, 2023-2033 (US$ Billion)
Figure 55 Other Technologies Market Share Forecast by Region, 2023 & 2033 (%)
Figure 56 Precision Medicine Market by End-users: Market Attractiveness Index
Figure 57 Precision Medicine Market Forecast by End-users, 2023-2033 (US$ Billion)
Figure 58 Precision Medicine Market Share Forecast by End-users, 2023, 2028, 2033 (%)
Figure 59 Hospitals Market Forecast by Region, 2023-2033 (US$ Billion)
Figure 60 Hospitals Market Share Forecast by Region, 2023 & 2033 (%)
Figure 61 Diagnostic Centres Market Forecast by Region, 2023-2033 (US$ Billion)
Figure 62 Diagnostic Centres Market Share Forecast by Region, 2023 & 2033 (%)
Figure 63 Research & academic institutes Market Forecast by Region, 2023-2033 (US$ Billion)
Figure 64 Research & academic institutes Market Share Forecast by Region, 2023 & 2033 (%)
Figure 65 Other End-users Market Forecast by Region, 2023-2033 (US$ Billion)
Figure 66 Other End-users Market Share Forecast by Region, 2023 & 2033 (%)
Figure 67 Precision Medicine Market Forecast by Region 2023 and 2033 (Revenue, CAGR%)
Figure 68 Precision Medicine Market Share Forecast by Region 2023, 2028, 2033 (%)
Figure 69 Precision Medicine Market by Region, 2023-2033 (US$ Billion, AGR %)
Figure 70 North America Precision Medicine Market Attractiveness Index
Figure 71 North America Precision Medicine Market by Region, 2023, 2028 & 2033 (US$ Billion)
Figure 72 North America Precision Medicine Market Forecast by Country, 2023-2033 (US$ Billion, AGR %)
Figure 73 North America Precision Medicine Market Share Forecast by Country, 2023 & 2033 (%)
Figure 74 North America Precision Medicine Market Forecast by Product Type, 2023-2033 (US$ Billion, AGR %)
Figure 75 North America Precision Medicine Market Share Forecast by Product Type, 2023 & 2033 (%)
Figure 76 North America Precision Medicine Market Forecast by Application, 2023-2033 (US$ Billion, AGR %)
Figure 77 North America Precision Medicine Market Share Forecast by Application, 2023 & 2033 (%)
Figure 78 North America Precision Medicine Market Forecast by Technology, 2023-2033 (US$ Billion, AGR %)
Figure 79 North America Precision Medicine Market Share Forecast by Technology, 2023 & 2033 (%)
Figure 80 North America Precision Medicine Market Forecast by End-users, 2023-2033 (US$ Billion, AGR %)
Figure 81 North America Precision Medicine Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 82 U.S. Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 83 Canada Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 84 Europe Precision Medicine Market Attractiveness Index
Figure 85 Europe Precision Medicine Market by Region, 2023, 2028 & 2033 (US$ Billion)
Figure 86 Europe Precision Medicine Market Forecast by Country, 2023-2033 (US$ Billion)
Figure 87 Europe Precision Medicine Market Share Forecast by Country, 2023 & 2033 (%)
Figure 88 Europe Precision Medicine Market Forecast by Product Type, 2023-2033 (US$ Billion)
Figure 89 Europe Precision Medicine Market Share Forecast by Product Type, 2023 & 2033 (%)
Figure 90 Europe Precision Medicine Market Forecast by Application, 2023-2033 (US$ Billion)
Figure 91 Europe Precision Medicine Market Share Forecast by Application, 2023 & 2033 (%)
Figure 92 Europe Precision Medicine Market Forecast by Technology, 2023-2033 (US$ Billion)
Figure 93 Europe Precision Medicine Market Share Forecast by Technology, 2023 & 2033(%)
Figure 94 Europe Precision Medicine Market Forecast by End-users, 2023-2033 (US$ Billion)
Figure 95 Europe Precision Medicine Market Share Forecast by End-users, 2023 & 2033(%)
Figure 96 Germany Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 97 UK Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 98 France Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 99 Italy Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 100 Spain Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 101 Switzerland Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 102 Netherlands Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 103 Rest of Europe Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 104 Asia Pacific Precision Medicine Market Attractiveness Index
Figure 105 Asia Pacific Precision Medicine Market by Region, 2023, 2028 & 2033 (US$ Billion)
Figure 106 Asia Pacific Precision Medicine Market Forecast by Country, 2023-2033 (US$ Billion)
Figure 107 Asia Pacific Precision Medicine Market Share Forecast by Country, 2023 & 2033 (%)
Figure 108 Asia Pacific Precision Medicine Market Forecast by Product Type, 2023-2033 (US$ Billion)
Figure 109 Asia Pacific Precision Medicine Market Share Forecast by Product Type, 2023 & 2033 (%)
Figure 110 Asia Pacific Precision Medicine Market Forecast by Application, 2023-2033 (US$ Billion)
Figure 111 Asia Pacific Precision Medicine Market Share Forecast by Application, 2023 & 2033 (%)
Figure 112 Asia Pacific Precision Medicine Market Forecast by Technology, 2023-2033 (US$ Billion)
Figure 113 Asia Pacific Precision Medicine Market Share Forecast by Technology, 2023 & 2033 (%)
Figure 114 Asia Pacific Precision Medicine Market Forecast by End-users, 2023-2033 (US$ Billion)
Figure 115 Asia Pacific Precision Medicine Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 116 Japan Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 117 China Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 118 India Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 119 Australia Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 120 South Korea Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 121 Singapore Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 122 Rest of Asia Pacific Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 123 Latin America Precision Medicine Market Attractiveness Index
Figure 124 Latin America Precision Medicine Market by Region, 2023, 2028 & 2033 (US$ Billion)
Figure 125 Latin America Precision Medicine Market Forecast by Country, 2023-2033 (US$ Billion)
Figure 126 Latin America Precision Medicine Market Share Forecast by Country, 2023 & 2033 (%)
Figure 127 Latin America Precision Medicine Market Forecast by Product Type, 2023-2033 (US$ Billion)
Figure 128 Latin America Precision Medicine Market Share Forecast by Product Type, 2023 & 2033 (%)
Figure 129 Latin America Precision Medicine Market Forecast by Application, 2023-2033 (US$ Billion)
Figure 130 Latin America Precision Medicine Market Share Forecast by Application, 2023 & 2033 (%)
Figure 131 Latin America Precision Medicine Market Forecast by Technology, 2023-2033 (US$ Billion)
Figure 132 Latin America Precision Medicine Market Share Forecast by Technology, 2023 & 2033 (%)
Figure 133 Latin America Precision Medicine Market Forecast by End-users, 2023-2033 (US$ Billion)
Figure 134 Latin America Precision Medicine Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 135 Brazil Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 136 Mexico Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 137 Argentina Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 138 Rest of Latin America Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 139 MEA Precision Medicine Market Attractiveness Index
Figure 140 MEA Precision Medicine Market by Region, 2023, 2028 & 2033 (US$ Billion)
Figure 141 MEA Precision Medicine Market Forecast by Country, 2023-2033 (US$ Billion)
Figure 142 MEA Precision Medicine Market Share Forecast by Country, 2023 & 2033 (%)
Figure 143 MEA Precision Medicine Market Forecast by Product Type, 2023-2033 (US$ Billion)
Figure 144 MEA Precision Medicine Market Share Forecast by Product Type, 2023 & 2033 (%)
Figure 145 MEA Precision Medicine Market Forecast by Application, 2023-2033 (US$ Billion)
Figure 146 MEA Precision Medicine Market Share Forecast by Application, 2023 & 2033 (%)
Figure 147 MEA Precision Medicine Market Forecast by Technology, 2023-2033 (US$ Billion)
Figure 148 MEA Precision Medicine Market Share Forecast by Technology, 2023 & 2033 (%)
Figure 149 MEA Precision Medicine Market Forecast by End-users, 2023-2033 (US$ Billion)
Figure 150 MEA Precision Medicine Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 151 GCC Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 152 South Africa Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 153 Egypt Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 154 Rest of MEA Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 155 Precision Medicine Market: Company Share/Ranking, 2022
Figure 156 Pfizer Inc. Inc: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 157 Pfizer Inc.: R&D, 2018-2022 (US$ Million, AGR%)
Figure 158 Pfizer Inc.: Regional Market Shares, 2022
Figure 159 Qiagen: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 160 Qiagen: R&D, 2018-2022 (US$ Million, AGR %)
Figure 161 Qiagen: Regional Market Shares, 2022
Figure 162 Quest Diagnostics Inc.: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 163 Agilent Technologies Inc.: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 164 Agilent Technologies Inc.: R&D, 2018-2022 (US$ Million, AGR %)
Figure 165 Agilent Technologies Inc.: Regional Market Shares, 2022
Figure 166 Illumina, Inc.: Net Revenue, 2018-2022 (US$ Million, AGR (%)
Figure 167 Illumina, Inc.: R&D, 2018-2022 (US$ Million, AGR %)
Figure 168 Illumina, Inc.: Regional Market Shares, 2022
Figure 169 Novartis AG: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 170 Novartis AG: R&D, 2018-2022(US$ Million, AGR %)
Figure 171 Novartis AG: Regional Market Shares, 2022
Figure 172 bioMerieux SA: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 173 bioMerieux SA: R&D, 2018-2022 (US$ Million, AGR %)
Figure 174 bioMerieux SA: Regional Market Shares, 2022
Figure 175 F. Hoffmann-La Roche Ltd: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 176 F. Hoffmann-La Roche Ltd: R&D, 2018-2022 (US$ Million, AGR (%))
Figure 177 F. Hoffmann-La Roche Ltd: Regional Market Shares, 2022
Figure 178 Abbott: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 179 Abbott: R&D, 2018-2022(US$ Million, AGR %)
Figure 180 Abbott: Regional Market Shares, 2022
Figure 181 Lilly.: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 182 Lilly.: R&D, 2018-2022 (US$ Million, AGR %)
Figure 183 Lilly.: Regional Market Shares, 2022
Figure 184 Thermo Fisher Scientific Inc..: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 185 Thermo Fisher Scientific Inc..: R&D, 2018-2022 (US$ Million, AGR %)
Figure 186 Thermo Fisher Scientific Inc..: Regional Market Shares, 2022
Figure 187 AstraZeneca: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 188 AstraZeneca: R&D, 2018-2022 (US$ Million, AGR %)
Figure 189 AstraZeneca.: Regional Market Shares, 2021
Figure 190 Myriad Genetics Inc.: Net Revenue, 2018-2022(US$ Million, AGR %)
Figure 191 Myriad Genetics Inc.: R&D, 2018-2022 (US$ Million, AGR %)
Figure 192 Myriad Genetics Inc.: Regional Market Shares, 2022
Figure 193 GSK plc: Net Revenue, 2018-2022(US$ Million, AGR %)
Figure 194 GSK plc: R&D, 2018-2022 (US$ Million, AGR %)
Figure 195 GSK plc: Regional Market Shares, 2022
Figure 196 Bristol-Myers Squibb Company: Net Revenue, 2018-2022(US$ Million, AGR %)
Figure 197 Bristol-Myers Squibb Company: R&D, 2018-2022 (US$ Million, AGR %)
Figure 198 Bristol-Myers Squibb Company: Regional Market Shares, 2022
Figure 199 Danaher: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 200 Danaher: R&D, 2018-2022 (US$ Million, AGR %)
Figure 201 Danaher: Regional Market Shares, 2022
Figure 202 Laboratory Corporation of America Holdings: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 203 Laboratory Corporation of America Holdings: Regional Market Shares, 2022
Figure 204 GE HealthCare: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 205 GE HealthCare: Regional Market Shares, 2022
Figure 206 Teva Pharmaceutical Industries Ltd: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 207 Teva Pharmaceutical Industries Ltd: R&D, 2018-2022 (US$ Million, AGR %)
Figure 208 Teva Pharmaceutical Industries Ltd: Regional Market Shares, 2022
Figure 209 NanoString Technologies, Inc.: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 210 NanoString Technologies, Inc.: R&D, 2018-2022 (US$ Million, AGR %)
Figure 211 NanoString Technologies, Inc.: Regional Market Shares, 2022
Figure 212 Bayer AG: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 213 Bayer AG: R&D, 2018-2022 (US$ Million, AGR %)
Figure 214 Bayer AG: Regional Market Shares, 2022
Figure 215 Biogen: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 216 Biogen: R&D, 2018-2022 (US$ Million, AGR %)
Figure 217 Biogen: Regional Market Shares, 2022
Figure 218 Johnson & Johnson Services, Inc.: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 219 Johnson & Johnson Services, Inc.: R&D, 2018-2022 (US$ Million, AGR %)
Figure 220 Johnson & Johnson Services, Inc.: Regional Market Shares, 2022

Companies Mentioned

Abbott
Abnova Corporation
Agilent Technologies Inc.
AstraZeneca
Bayer AG
Biogen
bioMérieux SA
Bristol-Myers Squibb Company
Danaher
F. Hoffmann-La Roche Ltd AG
GE HealthCare
GSK plc
Illumina, Inc.
Johnson & Johnson Services, Inc.
Laboratory Corporation of America Holdings
Lilly
Myriad Genetics Inc.
NanoString Technologies, Inc.
Novartis AG
Pfizer Inc.
Qiagen
Quest Diagnostics Incorporated
Teva Pharmaceutical Industries Ltd.
Thermo Fisher Scientific Inc.
Aetna
Allina Health
Almaden Genomics
Amoy Diagnostics Co. Ltd.
Ariana Pharma
Beam Therapeutics
BenevolentAI
Bitgenia
Bracco Imaging
Brammer Bio
Cancer Genetics, Inc.
Caris Life Sciences
Catalent
Cedars-Sinai Cancer
Central Glass Co. Ltd.
Charité - Universitätsmediz
Chugai Pharmaceutical Co., Ltd.
Cipherome, Inc.
CureMatch Inc
Cyclerion Therapeutics
Diatech Pharmacogenetics
DilenyTech
DNAnexus, Inc.
Enhanc3D Genomics
EONE-Diagnomics Genome Centre (EDGC)
Evotec SE
Exscientia
Foundation Medicine, Inc.
Fujitsu
Gate Neurosciences
Genetron Health
GeNeuro
Guardian Research Network (GRN)
HaemaLogix
Healiva
HealthPartners and Helix
HotSpot Therapeutics
Idoven
InnoSIGN
Insilico Medicine
Intelligene
Janssen Pharmaceutical Companies
Kartos Therapeutics
KeyZell
KPJ Healthcare Bhd
LabCorp's Diagnostics
Lunaphore
MedStar Health
Molecular Health GmbH
NeoGenomics Laboratories
NeraCare GmbH
New Era Capital Partners
Nouscom
Nucleai
Oncodesign
Oncologica Ltd.
Oncomine Dx
Ono Pharmaceutical Co., Ltd.
Owkin
Paragon Bioservices Inc.
Precision Biomonitoring Inc.
PrecisionLife Limited
Prometheus
Quest Diagnostics
Relay Therapeutics
Renalytix AI plc
Rhythm Pharmaceuticals, Inc.
RIKEN
F. Hoffmann-La Roche Ltd
Samsung Electronics Co.
Sanof
SEngine
Shuwen Biotech CO. LTD
Siemens Healthineers
SimpleTherapy
Sirona DX
SkylineDx
SOPHiA GENETICS
SQI Diagnostics Inc.
Tag.bio
Takeda Pharmaceutical Company Limited
Tempus
Tesis Biosciences
Ultivue
Variantyx
Zephyr AI, Inc.
Asian Cancer Research Group (ACRG)
Asian clinical Trials network for cancer (ATLAS)
Brazilian Ministry of Science, Technology & Innovation (MCTI)
Brazilian National Cancer Institute (INCA)
Centre for Excellence in Precision Medicine (CEPM)
Centers for Medicare and Medicaid Services
Centre for Proteomic & Genomic Research (CPGR)
Centre of Excellence in Genomic Medicine Research (CEGMR)
European Genome-Phenome Archive (EGA)
Genes2ME
GLOBOCAN
International Agency for Research on Cancer (IARC)
Massachusetts General Hospital (MGH)
Medical Research Future Fund (MRFF)
National Cancer Institute
National Cancer Registry Program of Indian Council of Medical Research (ICMR)
National Centre for Biotechnology Information (NCBI)
National Institutes of Health (NIH)
National Health and Medical Research Council (NHMRC)
Netherlands Cancer Institute (NKI)
Pharmaceuticals and Medical Devices Agency (PMDA)
Qatar Biomedical Research Institute (QBRI)
Regeneron Genetics Center (RGC)
Spanish Medical Oncology Society (SEOM)
Spanish Society of Anatomic Pathology (SEAP)
World Health Organisation (WHO)

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€4930EUR$5,127USD£3,950GBP
1 - 5 USER LICENSE PDF	The product is a PDF.	This is a 1-5 user license, allowing up to five users have access to the product.	€5617EUR$5,840USD£4,500GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€6865EUR$7,138USD£5,500GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€8675EUR$9,020USD£6,950GBP